382
Participants
Start Date
April 27, 2017
Primary Completion Date
December 17, 2021
Study Completion Date
December 17, 2021
Inclisiran
Inclisiran is a synthetic, chemically modified small interfering ribonucleic acid (siRNA) targeting proprotein convertase subtilisin kexin type 9 (PCSK9) messenger ribonucleic acid (mRNA) with a covalently attached triantennary N-acetylgalactosamine (GalNAc) ligand.
Evolocumab
Evolocumab is a fully human monoclonal antibody that inhibits PCSK9.
Novartis Investigative Site, New York
Novartis Investigative Site, Berlin
Novartis Investigative Site, Richmond
Novartis Investigative Site, Jacksonville
Novartis Investigative Site, Greenville
Novartis Investigative Site, Cincinnati
Novartis Investigative Site, Cincinnati
Novartis Investigative Site, Essen
Novartis Investigative Site, Indianapolis
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Amarillo
Novartis Investigative Site, Munich
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Winnipeg
Novartis Investigative Site, Brampton
Novartis Investigative Site, London
Novartis Investigative Site, Toronto
Novartis Investigative Site, Chicoutimi
Novartis Investigative Site, Montreal
Novartis Investigative Site, Sherbrooke
Novartis Investigative Site, Québec
Novartis Investigative Site, Québec
Novartis Investigative Site, St. Johns
Novartis Investigative Site, Leiden
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Deventer
Novartis Investigative Site, Eindhoven
Novartis Investigative Site, Goes
Novartis Investigative Site, Hoogeveen
Novartis Investigative Site, Hoogezand
Novartis Investigative Site, Hoorn
Novartis Investigative Site, The Hague
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Venlo
Novartis Investigative Site, Zwijndrecht
Novartis Investigative Site, Fowey
Novartis Investigative Site, Liskeard
Novartis Investigative Site, Penzance
Novartis Investigative Site, St Austell
Novartis Investigative Site, Torpoint
Novartis Investigative Site, Birmingham
Novartis Investigative Site, Edinburgh
Novartis Investigative Site, Exeter
Novartis Investigative Site, High Wycombe
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Novartis Investigative Site, Newcastle Upon Tyme
Novartis Investigative Site, Plymouth
Novartis Investigative Site, Worcester
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY